Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.675
+0.065 (1.80%)
At close: Nov 4, 2024, 4:00 PM
3.580
-0.095 (-2.59%)
After-hours: Nov 4, 2024, 4:23 PM EST
Kiora Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for KPRX stock has a target of 10, which predicts an increase of 172.11% from the current stock price of 3.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 22, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for KPRX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +172.11% | Aug 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $10 | Strong Buy | Maintains | $2 → $10 | +172.11% | Jul 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +389.80% | May 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +389.80% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $18 | Strong Buy | Maintains | $32 → $18 | +389.80% | Feb 9, 2024 |
Financial Forecast
Revenue This Year
16.86M
Revenue Next Year
2.08M
from 16.86M
Decreased by -87.68%
EPS This Year
1.37
from -24.25
EPS Next Year
-2.27
from 1.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.4M | 6.3M | 1.6M | ||
| Avg | 16.9M | 2.1M | 765,000 | ||
| Low | 15.7M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -62.6% | -24.2% | ||
| Avg | - | -87.7% | -63.2% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.79 | -1.79 | -1.10 | ||
| Avg | 1.37 | -2.27 | -1.83 | ||
| Low | 0.75 | -2.70 | -2.48 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.